Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline Instillation for Low Grade Bladder Cancer
NCT04147182Phase 1Unknown
- Start
- Dec 2018
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sodium chloride in bladder cancer. Primary endpoints: Incidence of Treatment-Emergent Adverse Events at 12 months and Satisfaction at 12 months. Status: unknown.
02
Drugs
sodium chloride
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT04147182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147182.